Search results
Beacon raises $170M for eye gene therapy; J&J confirms Carvykti survival benefit
BioPharma Dive· 14 hours agoForbion led the startup’s Series B round. Elsewhere, Vertex got an FDA decision date for its “vanza...
Forbion led the startup’s Series B round. Elsewhere, Vertex got an FDA decision date for its “vanza...